Latest revenue
$439.6M
as of 2026-04-03
Latest net income
$16.5M
as of 2026-04-03
Net margin
3.8%
as of 2026-04-03
Price · 5Y
Live market
delayed ≤15 min- Market cap
- $3.03B
- Enterprise value
- $3.03B
- P/E (trailing)
- 29.5×
- Forward P/E
- —
- P/B
- —
- Dividend yield
- 0.0%
- 52-wk high
- $123.78
- 52-wk low
- $62.00
- Beta
- —
- Shares out
- 34.0M
5-year trend
What this company does
ITEM 1. BUSINESS OVERVIEW Integer Holdings Corporation, headquartered in Plano, Texas, is one of the world’s largest medical device contract development and manufacturing organizations (“CDMOs”), serving the Cardio and Vascular, Neuromodulation, and Cardiac Rhythm Management markets. As a strategic partner of choice, we advance the goals of our medical device customers through industry-leading engineering and manufacturing, with a relentless commitment to quality, service, and innovation. Our brands include Greatbatch Medical® and Lake Region Medical®. Our primary customers include large, multi-national original equipment manufacturers (“OEMs”) and their affiliated subsidiaries. When used…
AI summary unavailable — showing raw filing excerpt
Generated from ITGR's filing dated 2026-02-23
Key risks
Table of Contents ITEM 1A. RISK FACTORS Our business faces many risks, and you should carefully consider the following risk factors, together with all of the other information included in this report, including the financial statements and related notes contained in Item 8, “Financial Statements and Supplementary Data,” and the discussion in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” of this report, when deciding to invest in us. Any of the risks discussed below, or elsewhere in this report or in our other SEC filings, could have a material impact on our business, financial condition or results of operations. Additional risks not…
AI summary unavailable — showing raw filing excerpt
Generated from ITGR's filing dated 2026-02-23
Profitability
Gross margin
27.0%
1.0%Operating margin
11.9%
1.6%Net margin
5.5%
20.6%Return on equity
6.3%
14.3%Return on assets
3.0%
22.6%Leverage
Debt / equity
1.11×
22.8%Long-term debt / equity
0.73×
20.9%Debt / assets
52.5%
10.8%Earnings tracker
| Quarter | Revenue | YoY | Net income | YoY | Net margin |
|---|---|---|---|---|---|
Q2 2026 2026-04-03 | $439.6M | +0.5% | $16.5M | +173.4% | 3.8% |
Q4 2025 2025-12-31 | $472.1M | +5.0% | $71.1M | +117.4% | 15.1% |
Q3 2025 2025-09-26 | $467.7M | +8.4% | $39.7M | +12.0% | 8.5% |
Q2 2025 2025-06-27 | $476.5M | +11.4% | $14.5M | -53.5% | 3.0% |
Q1 2025 2025-03-28 | $437.4M | +7.3% | $-22.5M | -209.6% | -5.1% |
Q4 2024 2024-12-31 | $449.5M | — | $32.7M | — | 7.3% |
Q3 2024 2024-09-27 | $431.4M | +8.7% | $35.4M | +30.0% | 8.2% |
Q2 2024 2024-06-28 | $427.9M | +7.0% | $31.2M | +30.3% | 7.3% |
Year-over-year change vs the same fiscal quarter one year prior. Revenue + net income sourced from SEC 10-Q / 10-K filings — no analyst-consensus dependency.
Industry trend
Electromedical & Electrotherapeutic Apparatus · SIC 3845
Your notes
Keep private notes on ITGR — thesis, target price, catalysts to watch.
Visible only to you. Never shared. Never used to train AI.
Insider activity
Insider buying
$500.3K
Insider selling
$3.0M
Net activity
−$2.5M
Distinct insiders
7
Open-market trades over the last 365 days.
Recent transactions
Source: SEC Form 4 filings. Officers, directors, and 10%+ owners must disclose share transactions within two business days. RSU grants and tax-withholding rows are excluded by default — compensation activity is not a trading signal.
Who owns ITGR
Institutional value
$1.78B
Total shares held
21.5M
Distinct holders
203
-118 vs prior
As of
2026-03-31
Prior: 2025-12-31
Filers with $100M+ AUM disclose holdings 45 days after quarter end.
Top institutional holders
| # | Manager | Shares | Value | QoQ change | Action |
|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 5.3M | $466.9M | +18.9K (+0.4%) | Added |
| 2 | VANGUARD PORTFOLIO MANAGEMENT LLC | 2.0M | $180.1M | — | New |
| 3 | Invesco Ltd. | 2.0M | $173.3M | +699.3K (+55.1%) | Added |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | 1.5M | $135.3M | — | New |
| 5 | DIMENSIONAL FUND ADVISORS LP | 1.5M | $130.6M | +90.3K (+6.5%) | Added |
| 6 | Hudson Bay Capital Management LP | 1.0M | $88.0M | — | New |
| 7 | CIBC Bancorp USA Inc. | 751.8K | $66.2M | — | New |
| 8 | COOKE & BIELER LP | 536.7K | $47.2M | -76.4K (-12.5%) | Trimmed |
| 9 | FRANKLIN RESOURCES INC | 335.8K | $29.6M | -216.5K (-39.2%) | Trimmed |
| 10 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 292.6K | $25.7M | -175.8K (-37.5%) | Trimmed |
| 11 | KENNEDY CAPITAL MANAGEMENT LLC | 287.8K | $25.3M | -12.7K (-4.2%) | Trimmed |
| 12 | HEARTLAND ADVISORS INC | 248.0K | $21.8M | +5.3K (+2.2%) | Added |
| 13 | UBS Group AG | 244.6K | $21.5M | +90.8K (+59.0%) | Added |
| 14 | VANGUARD FIDUCIARY TRUST CO | 242.9K | $21.4M | — | New |
| 15 | WELLS FARGO & COMPANY/MN | 240.5K | $21.2M | -27.5K (-10.3%) | Trimmed |
| 16 | CITIGROUP INC | 239.2K | $21.1M | +146.0K (+156.6%) | Added |
| 17 | Bank of New York Mellon Corp | 233.6K | $20.6M | -3.7K (-1.6%) | Trimmed |
| 18 | PRINCIPAL FINANCIAL GROUP INC | 221.0K | $19.4M | +15.2K (+7.4%) | Added |
| 19 | ENVESTNET ASSET MANAGEMENT INC | 194.2K | $17.1M | -7.7K (-3.8%) | Trimmed |
| 20 | ING GROEP NV | 175.0K | $15.4M | — | New |
Source: SEC Form 13F-HR. Positions aggregated across sub-managers within each firm. Options (puts/calls) excluded — common stock only.
Top questions investors are asking
Coming once ITGR's latest filing finishes processing.